Users Coming Off Weight-Loss Injections Gain Back Weight Far More Rapidly Compared to People Using Diet and Exercise

Fresh analysis reveals that patients who discontinue popular weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who stop traditional lifestyle plans.

Findings released in a major health publication demonstrates that while obese people often shed a large proportion of their body weight while using the jabs, the weight returns at an average rate of nearly a kilo each month once they quit.

"People buying such drugs need to be aware of the risk of rapid rebound weight gain when the therapy concludes," stated researcher Dr. Susan Jebb.

That rate of recovery suggests a return to pre-treatment weight in about 18 months.

Analyzing Therapies

The research, which reviewed dozens of trials involving over 9,000 of participants, contrasted the outcomes of the injectable medications with older methods.

The team emphasize that people who lose weight through lifestyle changes alone usually experience a slower creep back—approximately 0.1 kg a month—post-intervention.

The Reason for the Rapid Regain

Doctors believe the mode of action of the drugs explains the heightened rebound.

These medications mimic a body's own chemical called GLP-1, which moderates hunger.

"Long-term administration of GLP-1 concentrations several times higher than normal may cause the system to produce less of its own natural hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.

"Stopping of this GLP-1 'fix' leads to appetite is unsuppressed, making excessive eating a significant risk."

A Lifelong Issue?

Medical guidelines recommend the injections for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.

A number of clinicians say that, due to the likelihood of relapse, the treatment is often long-term.

This view is reinforced by drug manufacturers, who state that the results "underscore the persistent character of obesity," akin to managing diseases like diabetes.

User Testimonies

People who have come off the medication explain a powerful return of appetite.

"It was like a trigger activating and you're instantly starving," described one woman.

The struggle is compounded if patients have not developed lasting lifestyle or habit modifications during treatment.

Significant Adoption

Recent estimates suggest that millions of adults in the UK have used these injections in the past year, with interest remaining high.

• Adoption is more common among females compared to males.
• The middle-aged demographic shows the greatest usage rates.
• Many obtain the medications through private prescriptions rather than public health services.

In conclusion, clinicians caution that while the jabs are powerful tools for weight loss, they are not a standalone solution and maintained weight loss likely depends on ongoing lifestyle support.